Celebrate Polyphenol Day & Dr. Gundry’s 75th with Olive Oil
Created by Gundry MD, the 5th Annual National Polyphenol Day is July 11, 2025 Created by Gundry MD®, National Polyphenol Day is all about celebrating the...
Category : Public Health, Disease Prevention & Wellness
FDA Review Reexamines NurOwn® Treatment Effectiveness Evidence
BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer...
Alpharmaxim Uses Behavioral Science to Improve Neurodegenerative Prescribing
A groundbreaking new study, published in PLOS One, has uncovered key behavioural factors influencing how medications are prescribed to people living with neurodegenerative diseases. The findings...
Neurent Medical Expands Access After Cigna OKs NEUROMARK®
Effective September 15, CPT 31242 is no longer considered experimental, clearing an important barrier for ENT physicians treating chronic rhinitis. Neurent Medical, a leader in non-surgical...
Breakthrough T1D Joins ADA 85th Sessions to Highlight Research Advances
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered with researchers, diabetes professionals, and other leaders in T1D...
SDU and PKU Discover New Mechanism in Glucose Regulation
On May 29, 2025, Professor Sun Jinpeng’s team and Professor Yu Xiao’s team at Shandong University, collaborating with Professor Jiang Changtao from Peking University, Professor Pang Yanli, and Professor Ji Linong, published a research...
Mirion Medical to Showcase Radiopharma Solutions at SNMMI 2025
Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to...
Immuno Cure & PharmaJet Team Up on Needle-Free HIV DNA Vaccine Trial
Immuno Cure BioTech (“Immuno Cure“), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to...
Xaira Launches Largest Public Genome-Wide Perturb-seq Dataset for AI
Xaira Therapeutics today announced a significant leap forward in developing AI-driven virtual cell models with the release of “X-Atlas/Orion,” the largest publicly available Perturb-seq atlas. This...
ReGelTec Treats First U.S. Patient in HYDRAFIL Low Back Pain Trial
ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has...
FRIC Completes Enrollment in TRANSFORM II Trial on Coronary Care
Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate...
FDA Grants Priority Review for Zoliflodacin with Dec 2025 PDUFA
FDA is expected to notify Innoviva Specialty Therapeutics regarding its decision to conduct an Advisory Committee Meeting in the Day 74 letter If approved, zoliflodacin...
Sensible Biotech Cuts Cell-Based mRNA Optimization Time 90%+ with AI
https://bi-journal.com/creatopy-unveils-live-data-with-20-growth-boost/Sensible Biotechnologies, a biotechnology company pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics, today announced an initiative to accelerate the development...
Natura Adds Smell Test to Detect Early Neuro Issues
A pioneering project in the product catalog introduces an olfactory test with unprecedented scents to promote women’s health and well-being The loss or alteration of...
Vera Whole Health Expands Primary Care Access in Virginia
Vera Whole Health recently opened its first advanced primary care center in Richmond, Virginia, after a recent study identified the Commonwealth as experiencing a primary care...